01:38 PM EDT, 09/18/2024 (MT Newswires) -- (Updates with latest stock movement in the headline and first paragraph.)

Vivos Therapeutics ( VVOS ) shares jumped 69% in recent Wednesday training after the company said it received the US Food and Drug Administration's 510(k) clearance for its oral medical device, which treats moderate to severe obstructive sleep apnea.

The company said the noninvasive, safe, and effective device is part of its CARE line and intended for children diagnosed with obstructive sleep apnea or snoring who need orthodontic treatment.

The approval was based on a multi-site, multi-nation study in pediatric patients.

Price: 4.73, Change: +1.93, Percent Change: +68.96